Lupus nephritis

• Novartis

  Company1 trialPhase 2240 people

• Red de Terapia Celular

  Company1 trialPhase 220 people

• Mansoura University

  2 trialsPhase 4184 people

• RenJi Hospital

  1 trialPhase 430 people

• Peking Union Medical College Hospital

  1 trialPhase 2/320 people

• Ain Shams University

  2 trialsPhase 2122 people

• Lingyun Sun

  1 trialPhase 2230 people

• The University of Hong Kong

  1 trialPhase 2150 people

National Institute of Arthritis and Musculoskeletal and Skin DiseasesUS$272.6kNational Institute of Diabetes and Digestive and Kidney DiseasesUS$364.6k2 grants since 2024

• Early and Personalized Cardiovascular Disease Preventive Care in Lupus Nephritis (EPiC-LN)

  National Institute of Arthritis and Musculoskeletal and Skin DiseasesYale UniversityUS$171k2024–2029

• Dapagliflozin in Active Lupus Nephritis: A Pilot and Feasibility Randomized Trial

  National Institute of Diabetes and Digestive and Kidney DiseasesBrigham and Women's HospitalUS$364.6k2026–2028